Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (35)

2023

  1. ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482

  2. Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response

    Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 1, pp. 1-13

  3. Role of Different Health Care Professionals in the Management of Asthma Patients: The GEMA-FORUM IV Task Force

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 3, pp. 214-217

2022

  1. Cluster Subanalysis of Patients With Severe Asthma Who Responded to Omalizumab

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 3, pp. 213-215

2021

  1. Clinical recommendations for the management of biological treatments in severe asthma patients: A consensus statement

    Journal of Investigational Allergology and Clinical Immunology, Vol. 31, Núm. 1, pp. 36-43

  2. Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 7, pp. 2725-2731

2020

  1. Fenoma study: Achieving full control in patients with severe allergic asthma

    Journal of Asthma and Allergy, Vol. 13, pp. 159-166

  2. Referral recommendations for adult emergency department patients with exacerbated asthma

    Emergencias, Vol. 32, Núm. 4, pp. 258-268

2019

  1. Benralizumab: A New approach for the treatment of severe eosinophilic asthma

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 2, pp. 84-93

  2. Selection of biologics in severe asthma: A multifaceted algorithm

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 4, pp. 325-328

  3. Severe asthma phenotypes in patients controlled with omalizumab: A real-world study

    Respiratory Medicine, Vol. 159

  4. Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018

    Allergy: European Journal of Allergy and Clinical Immunology

2018

  1. Consensus document on dog and cat allergy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 6, pp. 1206-1222

2017

  1. Allergy rhinitis: Similarities and differences between children and adults

    Rhinology, Vol. 55, Núm. 4, pp. 326-331

  2. Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN Study

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 72, Núm. 6, pp. 959-966

  3. Omalizumab is equally effective in persistent allergic oral corticosteroid-dependent asthma caused by either seasonal or perennial allergens: A pilot study

    International Journal of Molecular Sciences, Vol. 18, Núm. 3

2016

  1. Allergic rhinitis causes loss of smell in children: The OLFAPEDRIAL study

    Pediatric Allergy and Immunology, Vol. 27, Núm. 8, pp. 867-870

2015

  1. Clinical management and use of health care resources in the treatment of nasal polyposis in Spanish allergy centers: The POLAR study

    Journal of Investigational Allergology and Clinical Immunology, Vol. 25, Núm. 4, pp. 276-282

  2. Relationship between serum total IgE and disease severity in patients with allergic asthma in Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 25, Núm. 2, pp. 120-127

2013

  1. Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain

    Pediatric Allergy and Immunology, Vol. 24, Núm. 7, pp. 678-684